# Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

> **NCT00179062** · NA · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 300 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Depressive Disorder, Major
- Bipolar Disorder

## Interventions

- **DRUG:** olanzapine versus risperidone

## Key facts

- **NCT ID:** NCT00179062
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2008-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179062, "Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00179062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*